World's first generic to leading GnRH analogue with controlled release
Xbrane is pioneering high demand biosimilars.
OUTPERFORMING INDUSTRY STANDARDS BY DEVELOPING BIOSIMILARS WITH NEXT GENERATION TECHNOLOGY
Enabling access to critical medication for life critical diseases
Investors
Latest News
-
Xbrane Biopharma AB utser Dina Jurman, Head of Clinical Affairs, till medlem i ledningsgruppen
Read more >> -
Xbrane Biopharma AB appoints Dina Jurman, Head of Clinical Affairs, to management team
Read more >> -
Xbrane Biopharma AB bjuder in till bolagspresentation 12 oktober i Stockholm
Read more >> -
Xbrane Biopharma AB: Xbrane deltar på Carnegie Nordic HealthCare Day i New York, 5 december
Read more >> -
Xbrane Biopharma AB: Xbrane attends Carnegie Nordic HealthCare Day in New York, 5 December
Read more >>
Events
-
09 Jan 2017
J.P. Morgan 35th Annual Healthcare Conference, January 9-12
Read more >>
X
